{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/syphilis/diagnosis/when-to-suspect-syphilis/","result":{"pageContext":{"chapter":{"id":"bc588915-36d7-5368-b3b1-55539fe07a98","slug":"when-to-suspect-syphilis","fullItemName":"When to suspect syphilis","depth":2,"htmlHeader":"<!-- begin field 5170f147-60a8-4d56-b99e-d21b5cce2248 --><h2>When should I suspect syphilis?</h2><!-- end field 5170f147-60a8-4d56-b99e-d21b5cce2248 -->","summary":"","htmlStringContent":"<!-- begin item 332a5e86-6bff-40c2-94a5-f9283aed9ab0 --><!-- begin field 4e383e48-2c9e-4631-a21d-aab127188d53 --><ul><li><strong>Syphilis can present with a wide range of nonspecific symptoms — in some people infection may be asymptomatic. As a result diagnosis can be delayed or missed</strong>.</li><li><strong>Suspect syphilis if there is a history or presence of any of the following, especially if there are any </strong><a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/background-information/risk-factors/\">risk factors</a>: <ul><li><strong>Genital lesion(s)</strong> — the characteristic feature of <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/diagnosis/when-to-suspect-syphilis/#primary-syphilis\">primary syphilis</a> is a solitary, painless, indurated, genital ulcer (chancre) with a clean base and sharp border.<ul><li>Lesions may present atypically and be painful, multiple, or extra-genital.</li><li>Associated regional lymphadenopathy is common.</li></ul></li><li><strong>A non-pruritic maculopapular rash</strong> — rash typically involves the palms of the hands and soles of the feet.</li><li><strong>Moist wart-like lesions</strong> (condylomata lata) — usually develop at sites of skin friction such as perianal and vulval regions, under the breasts, and axillae.</li><li><strong>Patchy lesions on the oral mucosa</strong> (‘snail tract’ lesions).</li><li><strong>Generalized lymphadenopathy</strong>.</li><li><strong>Unexplained neurological or ophthalmological symptoms</strong>.</li></ul></li><li><strong>The presence of:</strong><ul><li>Chancre may indicate primary syphilis — for more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/diagnosis/when-to-suspect-syphilis/#primary-syphilis\">primary syphilis</a>. </li><li>A maculopapular rash, condylomata lata, oral lesions, generalized lymphadenopathy, unexplained neurological or ophthalmological symptoms may indicate secondary syphilis — for more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/diagnosis/when-to-suspect-syphilis/#secondary-syphilis\">secondary syphilis</a>. </li></ul></li><li><strong>Tertiary syphilis</strong> rarely presents in primary care — this may be partly due to widespread use of treponemicidal antibiotics for other infections.<ul><li>Clinical features of tertiary syphilis are varied, non-specific and can include cardiovascular, neurological, ocular and cutaneous symptoms and signs — for more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/diagnosis/when-to-suspect-syphilis/#tertiary-syphilis\">Tertiary syphilis</a>. </li></ul></li></ul><!-- end field 4e383e48-2c9e-4631-a21d-aab127188d53 --><!-- end item 332a5e86-6bff-40c2-94a5-f9283aed9ab0 -->","topic":{"id":"e20bf9b2-b7e3-5fd7-8829-79eff4ba17c6","topicId":"acdacd5c-088e-4bc3-b3f7-ec4a5cdf69d3","topicName":"Syphilis","slug":"syphilis","lastRevised":"Last revised in December 2019","chapters":[{"id":"e937b36a-5802-56e1-8c33-d31a18aa8993","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8e1009a7-fe76-55c5-a3b4-71f4ab22bd6e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3744efb5-ed9a-556d-b9ca-9497279f7760","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1a6d6164-e61e-5a2b-899c-b42fdd49c070","slug":"changes","fullItemName":"Changes"},{"id":"42b3bae7-13c9-5f24-8610-e6373d51db6c","slug":"update","fullItemName":"Update"}]},{"id":"783939a0-7dd0-51dc-b0f1-1a79adaeeca2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"481c647b-0185-5ec1-944f-ea3f095a698e","slug":"goals","fullItemName":"Goals"},{"id":"5d1c604c-5520-5fd3-906b-277d5bc648e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c1d0b67c-29a5-571e-a1e8-8037aa0cca4c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7c0ed1af-9d86-5a85-a39d-bac1f3ee5aa6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b5682ffb-43d2-5180-b6ef-2442bbeddb7f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"46feecc4-1ab5-56cc-88d4-0a134227de45","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4bd10070-ee64-5280-b905-06b3eb114be4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d6720e54-e02c-58ce-b1a6-033c00e802a7","slug":"definition","fullItemName":"Definition"},{"id":"a0c2113e-ec1b-5779-a10a-478a338f5123","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6dd4a0d4-fa9a-593e-888e-9e2f53fd28f7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b748bc0a-b4dd-5cd5-a38c-5a8565c1a29a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"76255843-9dc0-5005-8f9d-8ad229263649","slug":"complications","fullItemName":"Complications"}]},{"id":"f6319d5a-f16e-52a4-85ba-52fc5bdf0dfd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bc588915-36d7-5368-b3b1-55539fe07a98","slug":"when-to-suspect-syphilis","fullItemName":"When to suspect syphilis"},{"id":"6c61a9cf-feda-52ea-b119-caf357efc7b1","slug":"assessment","fullItemName":"Assessment"},{"id":"ca12c8de-69c5-5487-9003-b91829ef1e03","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eb1d937a-afbb-5c69-807a-d6560cf1f127","fullItemName":"Management","slug":"management","subChapters":[{"id":"4f71ffc0-f98f-5f3f-9752-9b49ae232b3f","slug":"management-of-suspected-syphilis","fullItemName":"Scenario: Management of suspected syphilis"}]},{"id":"94de066c-68d9-5f6d-93f5-8e51c88d0606","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ec180069-3dfc-52bb-8d33-474b29350978","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5989431d-2289-5a0d-8965-3fb04b1df99d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9a2ece67-c769-5551-bfb8-806b9499e079","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"daa5da38-6a12-51e2-88c0-c16841f9c9d8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18097171-0d2a-50aa-bf36-707fb65c028c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1ec2e8ce-2b99-5671-b5e5-14986c70f439","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0656a654-b988-57ed-b218-fb52feabfa93","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f6319d5a-f16e-52a4-85ba-52fc5bdf0dfd","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"212fa6d6-17e9-543b-ba15-b1055bd8573f","slug":"primary-syphilis","fullItemName":"Primary syphilis","depth":3,"htmlHeader":"<!-- begin field 5c79cecf-ecdd-4bff-92c9-f81e7c551ed6 --><h3>Primary syphilis</h3><!-- end field 5c79cecf-ecdd-4bff-92c9-f81e7c551ed6 -->","summary":null,"htmlStringContent":"<!-- begin item b752415b-900c-409e-b70f-6cea742412b0 --><!-- begin field 1fc7c015-2914-438d-b321-71bcab829942 --><p>​​​​​​<strong>Table 1: Clinical features of primary syphilis</strong></p><table data-table-id=\"57a9e9af-7820-463a-8d81-acce014c4ff2\"><thead><tr><th scope=\"col\"><p><strong>Timing</strong></p></th><th colspan=\"2\" scope=\"col\"><p><strong>Clinical features (any or several may be present)</strong></p></th></tr></thead><tbody><tr><td rowspan=\"2\"><p>Onset: 9–90 days after exposure (mean 21 days)</p><p> </p><p>Resolution: usually resolves spontaneously over 3–10 weeks</p></td><td><p>Chancre</p></td><td><ul><li>Solitary, painless, indurated ulcer with a clean base and well defined margin (chancre) at original site of inoculation.</li><li>Chancre develops from a single papule or plaque.</li><li>Usually genital but may be extra-genital (anal, rectal, oral or on the hands).</li><li>May go unnoticed if painless and not visible (for example rectal).</li><li>Can be multiple, painful and/or purulent — multiple lesions or atypical features may be present in HIV co-infection.</li></ul></td></tr><tr><td><p>Lymphadenopathy</p></td><td><ul><li>Chancre may be associated with local lymphadenopathy — this may be subtle.</li></ul></td></tr></tbody></table><p><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Clement, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Watts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]</p><!-- end field 1fc7c015-2914-438d-b321-71bcab829942 --><!-- end item b752415b-900c-409e-b70f-6cea742412b0 -->","subChapters":[]},{"id":"0df725a4-4797-5172-95af-c6db038ac9c6","slug":"secondary-syphilis","fullItemName":"Secondary syphilis","depth":3,"htmlHeader":"<!-- begin field ad2a6f1e-0b06-4af6-b11e-6e11f53c5d85 --><h3>Secondary syphilis</h3><!-- end field ad2a6f1e-0b06-4af6-b11e-6e11f53c5d85 -->","summary":null,"htmlStringContent":"<!-- begin item e1ad6ef3-987f-4daf-a941-e6ccbd6454bf --><!-- begin field 1b0d74ed-f5ed-4b35-8e6b-abcabd225970 --><p><strong>Table 2: Clinical features of secondary syphilis</strong></p><table data-table-id=\"282f6d50-8252-4628-897a-acce014c97f7\"><thead><tr><th scope=\"col\"><p><strong>Timing</strong></p></th><th colspan=\"2\" scope=\"col\"><p><strong>Clinical features (any or several may be present)</strong></p></th></tr></thead><tbody><tr><td rowspan=\"5\"><p>Onset: 4–12 weeks after appearance of initial chancre</p><p> </p><p>Resolution: untreated symptoms slowly resolve over 3–12 weeks but may recur (approximately 25% of cases).</p><p> </p><p> </p></td><td><p>Systemic features</p></td><td><ul><li>Fever.</li><li>Malaise.</li><li>Headache.</li><li>Generalized lymphadenopathy.</li><li>Hepatitis.</li><li>Splenomegaly.</li><li>Glomerulonephritis.</li></ul></td></tr><tr><td><p>Skin lesions</p></td><td><ul><li>Skin involvement occurs in around 90% of cases.</li><li>Rash – usually non-pruritic, maculopapular and generalized (may only affect soles and palms).</li><li>Condylomata lata – grey/white moist warty lesions most commonly on oral/genital mucosa or perianal area.</li><li>Atypical presentations are more common in HIV co-infection.</li></ul></td></tr><tr><td><p>Alopecia</p></td><td><ul><li>Patchy hair loss of the scalp, beard and eyebrows.</li></ul></td></tr><tr><td><p>Mucous patches</p></td><td><ul><li>Oval, shallow, ulcerative patches with raised silver borders sometimes known as ‘snail tract’ ulcers.</li><li>May develop on oral or genital mucosa.</li></ul></td></tr><tr><td><p>Early neurosyphilis</p></td><td><ul><li>Occurs in a small number of people (1–2%).</li><li>Meningitis.</li><li>Cranial nerve palsies (in particular II and VIII).</li><li>Hearing loss.</li><li>Ocular disease including optic neuropathy, uveitis and retinitis.</li><li>Infectious arteritis (ischaemia, thrombosis, infarction).</li><li>People with HIV co-infection may be at increased risk of neurological complications and ocular syphilis.</li></ul></td></tr></tbody></table><p><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Clement, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Watts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>] </p><!-- end field 1b0d74ed-f5ed-4b35-8e6b-abcabd225970 --><!-- end item e1ad6ef3-987f-4daf-a941-e6ccbd6454bf -->","subChapters":[]},{"id":"482de5cf-0e7d-5f65-a311-1d30896eff99","slug":"latent-syphilis","fullItemName":"Latent syphilis","depth":3,"htmlHeader":"<!-- begin field 700c9604-6be2-4dc8-9c46-ab250127f868 --><h3>Latent syphilis</h3><!-- end field 700c9604-6be2-4dc8-9c46-ab250127f868 -->","summary":null,"htmlStringContent":"<!-- begin item b08065e7-9422-4b8d-938d-ab250127f833 --><!-- begin field 51f549ca-d990-4281-8dee-ab250127f868 --><p><strong>Table 3: Clinical feature of latent syphilis</strong></p><table data-table-id=\"3dfb62f6-47a2-44cc-ad74-acce014c99a4\"><thead><tr><th scope=\"col\">Timing</th><th colspan=\"2\" scope=\"col\">Clinical features</th></tr></thead><tbody><tr><td><p>Early latent syphilis – less than 2 years duration from initial infection.</p><p> </p><p>Late latent syphilis – more than 2 years duration from initial infection.</p></td><td><p>Asymptomatic</p></td><td><ul><li>Serological evidence of infection in the absence of clinical features.</li><li>Around 25% of people have a recurrence of secondary disease during the early latent stage.</li></ul></td></tr></tbody></table><p><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Clement, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Watts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]</p><!-- end field 51f549ca-d990-4281-8dee-ab250127f868 --><!-- end item b08065e7-9422-4b8d-938d-ab250127f833 -->","subChapters":[]},{"id":"47439660-3c7c-59e8-bfc2-86f182667fa8","slug":"tertiary-syphilis","fullItemName":"Tertiary syphilis","depth":3,"htmlHeader":"<!-- begin field 045c5583-f1f7-4276-b46a-e1051316de60 --><h3>Tertiary syphilis</h3><!-- end field 045c5583-f1f7-4276-b46a-e1051316de60 -->","summary":null,"htmlStringContent":"<!-- begin item 5f87d478-1a6b-411c-83b4-ecad95d23829 --><!-- begin field 12438f86-c13c-40b8-9e8d-0e0a86e104b7 --><p><strong>Table 4: Clinical features of tertiary syphilis</strong></p><table data-table-id=\"42755266-800b-4edf-ac18-acce014c06f9\"><thead><tr><th scope=\"col\"><p><strong>Timing</strong></p></th><th colspan=\"2\" scope=\"col\"><p><strong>Clinical features (any or several may be present)</strong></p></th></tr></thead><tbody><tr><td rowspan=\"3\"><p>15 to 40 years after initial infection</p></td><td><p>Gummatous syphilis</p></td><td><ul><li>Gumma — granulomatous lesions with a necrotic centre.</li><li>Can develop anywhere but most often affect skin and bone.</li></ul></td></tr><tr><td><p>Cardiovascular syphilis</p></td><td><ul><li>Cardiovascular disease — often due to vasculitis and chronic inflammation of the aortic vasa vasorum.</li><li>Aortic regurgitation.</li><li>Aortic aneurysm.</li><li>Heart failure.</li><li>Angina.</li></ul></td></tr><tr><td><p>Neurosyphilis</p></td><td><ul><li>Tabes dorsalis (inflammation of spinal dorsal column/nerve roots) — may present with ‘lightening pains’, paraesthesia, Charcot’s joints, pupillary change, absent reflexes, joint position and vibration sense. </li><li>General paresis (cortical neuronal loss) — may present with forgetfulness and personality change which develop into severe dementia. Seizures and hemiparesis may occur.</li></ul></td></tr></tbody></table><p><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Clement, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Watts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]</p><!-- end field 12438f86-c13c-40b8-9e8d-0e0a86e104b7 --><!-- end item 5f87d478-1a6b-411c-83b4-ecad95d23829 -->","subChapters":[]},{"id":"454cdef9-acf2-5fba-ba17-c12c9bde103b","slug":"basis-for-recommendation-99b","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field ca486ce9-0600-49f6-9a3d-5f292c66854d --><h3>Basis for recommendation</h3><!-- end field ca486ce9-0600-49f6-9a3d-5f292c66854d -->","summary":null,"htmlStringContent":"<!-- begin item 99bd95ee-1437-4868-ac65-04c7639d7c58 --><!-- begin field 74a5f792-045c-41a8-a168-0cf1b113604f --><p>The recommendations on the clinical features of syphilis are based on clinical guidelines <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>], <em>UK national guidelines on the management of syphilis 2015</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>], <em>WHO guidelines for the treatment of Treponema pallidum (syphilis)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>] and <em>Syphilis. Management summary</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>], <em>UK national guidelines on the management of syphilis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>], the reports <em>Syphilis and congenital syphilis in Europe. A review of epidemiological trends (2007-2018) and options for response</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>] and <em>Addressing the increase in syphilis in England: PHE Action Plan</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Clement, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Watts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>]. </p><ul><li>It is widely agreed that diagnosis of syphilis can be easily delayed or missed as presentation of both early and late syphilis is highly variable, non-specific and clinical features can be subtle [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Thakrar, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]. <ul><li>In addition, the chancre of primary syphilis can develop on sites which are not visible (for example, the rectum) and if painless, missed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">IUSTI, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]. </li></ul></li><li>Co-infection with HIV does not lead to more severe early syphilis symptoms however, atypical presentations are more common [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]. <ul><li>Co-infection with HIV may predispose to neuro-ophthalmological complications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Peeling, 2017</a>]. </li></ul></li></ul><!-- end field 74a5f792-045c-41a8-a168-0cf1b113604f --><!-- end item 99bd95ee-1437-4868-ac65-04c7639d7c58 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}